SUSQUEHANNA INTERNATIONAL GROUP, LLP - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 47 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$13,000
-76.4%
20,175
-83.5%
0.00%
Q2 2016$55,000
+17.0%
122,324
+171.4%
0.00%
Q1 2016$47,000
-76.4%
45,077
-33.3%
0.00%
Q4 2015$199,000
-15.3%
67,615
-9.2%
0.00%
Q3 2015$235,000
-66.1%
74,473
-36.5%
0.00%
Q2 2015$694,000
-4.3%
117,281
+73.0%
0.00%
Q1 2015$725,000
-24.1%
67,800
-33.3%
0.00%
Q4 2014$955,000
-50.4%
101,700
-59.4%
0.00%
-100.0%
Q3 2014$1,924,000
-39.3%
250,500
-29.1%
0.00%0.0%
Q2 2014$3,171,000353,1430.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders